ArticleJCI insight2021

p66ShcA potentiates the cytotoxic response of triple-negative breast cancers to PARP inhibitors.

Eduardo Cepeda Cañedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.